Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Wakelee, H."" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer.
Autorzy:
Chen H; Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA.
Modiano MR; Arizona Oncology/Arizona Clinical Research Center, 1620W. St Mary's Rd, Tucson, AZ 85745, USA.
Neal JW; Department of Medicine, Stanford University School of Medicine and Cancer Institute, 875 Blake Wilbur Dr, Stanford, CA 94305, USA.
Brahmer JR; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting/Blaustein CRB, 1650 Orleans St., G94, Baltimore, MD 21231, USA.
Rigas JR; Department of Medicine, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, 1 Medical Center Drive, Lebanon, NH 03756, USA.
Jotte RM; Rocky Mountain Cancer Centers, 1800 Williams Street, Suite 200, Denver, CO 80218, USA.
Leighl NB; Department of Medicine, Princess Margaret Hospital and University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada.
Riess JW; Department of Medicine, Stanford University School of Medicine and Cancer Institute, 875 Blake Wilbur Dr, Stanford, CA 94305, USA.
Kuo CJ; Department of Medicine, Stanford University School of Medicine and Cancer Institute, 875 Blake Wilbur Dr, Stanford, CA 94305, USA.
Liu L; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Gao B; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Dicioccio AT; Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Adjei AA; Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA.
Wakelee HA; Department of Medicine, Stanford University School of Medicine and Cancer Institute, 875 Blake Wilbur Dr, Stanford, CA 94305, USA.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2014 Feb 04; Vol. 110 (3), pp. 602-8. Date of Electronic Publication: 2013 Nov 28.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma, Non-Small-Cell Lung/*drug therapy
Cisplatin/*administration & dosage
Glutamates/*administration & dosage
Guanine/*analogs & derivatives
Receptors, Vascular Endothelial Growth Factor/*administration & dosage
Recombinant Fusion Proteins/*administration & dosage
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Cisplatin/adverse effects ; Disease-Free Survival ; Drug-Related Side Effects and Adverse Reactions/classification ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; Glutamates/adverse effects ; Guanine/administration & dosage ; Guanine/adverse effects ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Pemetrexed ; Receptors, Vascular Endothelial Growth Factor/adverse effects ; Recombinant Fusion Proteins/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours.
Autorzy:
Diaz-Padilla I; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University Health Network, University of Toronto, 610 University Avenue, 5-700, Toronto, Ontario M5G 2M9, Canada. />Siu LL
San Pedro-Salcedo M
Razak AR
Colevas AD
Shepherd FA
Leighl NB
Neal JW
Thibault A
Liu L
Lisano J
Gao B
Lawson EB
Wakelee HA
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2012 Aug 07; Vol. 107 (4), pp. 604-11. Date of Electronic Publication: 2012 Jul 17.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Cisplatin/*administration & dosage
Glutamates/*administration & dosage
Guanine/*analogs & derivatives
Neoplasms/*drug therapy
Recombinant Fusion Proteins/*administration & dosage
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Administration Schedule ; Fatigue/chemically induced ; Female ; Guanine/administration & dosage ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Nausea/chemically induced ; Pemetrexed ; Receptors, Vascular Endothelial Growth Factor ; Recombinant Fusion Proteins/blood
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies